$MAJI just filed to change "business description" - Why is this important?

Was reading a few posts about how this can be big news.... but I am lost, they are just changing their business description on OTCmarkets.

This is the response from the company

"Although the Company has exited the Cannabis space OTC wishes us to formally announce the exit so they can update our "Industry" to Wellness/Healthcare. Why do we care? because there are investors who wish to support the stock, but can't with our industry as cannabis, compliance will not allow the trades to be executed."

**Is there something more I am not seing?**

Here is the Press Release: [https://www.otcmarkets.com/stock/MAJI/news/NexTel-Medical-Corp-Announces-Strategic-Exit-from-Cannabis-and-CBD-Sector-to-Pivot-100-to-Wellness-and-Healthcare?id=527817](https://www.otcmarkets.com/stock/MAJI/news/NexTel-Medical-Corp-Announces-Strategic-Exit-from-Cannabis-and-CBD-Sector-to-Pivot-100-to-Wellness-and-Healthcare?id=527817)

"**ORLANDO, FL — July 9, 2026** — NexTel Medical Corp. (f/k/a Exousia Pro, Inc.) (OTCPK: MAJI), a clinical-stage biotechnology company specializing in proprietary exosome-based delivery systems, today announced it has formally ceased all operations within the cannabis and CBD industries. The Company will not be loading CBD into exosomes.  Moving forward, the Company is entirely committed to the wellness and healthcare sectors.

**About NexTel Medical Corp.**

NexTel Medical Corp. (OTCPK: MAJI) is a pioneering biotechnology leader at the forefront of exosome research, clinical diagnostics, and wellness accessibility. The Company specializes in developing proprietary, next-generation, exosome-based delivery systems and non-invasive screening tools designed to revolutionize both therapeutic and diagnostic modalities."